Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 7, 2014; 20(45): 16868-16880
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.16868
Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.16868
Pharmacologic therapy for acute pancreatitis
Swetha Kambhampati, Walter Park, Aida Habtezion, Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States
Author contributions: All the authors contributed to this manuscript.
Supported by Robert Wood Johnson Foundation grant (to Habtezion A); National Institutes of Health Grant DK092421 (to Habtezion A); and American College of Gastroenterology (to Park W)
Correspondence to: Dr. Aida Habtezion, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, United States. aidah@stanford.edu
Telephone: +1-650-7253362 Fax: +1-650-7235488
Received: May 22, 2014
Revised: July 23, 2014
Accepted: October 15, 2014
Published online: December 7, 2014
Processing time: 202 Days and 15.1 Hours
Revised: July 23, 2014
Accepted: October 15, 2014
Published online: December 7, 2014
Processing time: 202 Days and 15.1 Hours
Core Tip
Core tip: Currently there are no approved therapies for acute pancreatitis. This review summarizes and discusses pre-clinical and clinical studies in acute pancreatitis and also discusses potential promising therapies.